CenterWatch Announces -- The Revised ICH E8: A Guide to New Clinical Trial Requirements Management Report
Friday, March 27, 2020
ICH E8(R1) is impacting how one conducts clinical trials. What must change in your SOPs, procedures, processes and documentation?
FALLS CHURCH, Va., March 20, 2020 /PRNewswire-PRWeb/ -- With ICH E8(R1) set to be adopted in June 2020, how one plans, designs and conducts clinical trials will look different than they do today. Be ready to implement the new guidelines.
The Revised ICH E8: A Guide to New Clinical Trial Requirements management report shows readers how to leverage the revised guidelines' quality-by-design approaches, expanded study designs and data source considerations. With this knowledge, one can adapt, continuing to provide a quality-driven framework that leads to efficient and timely decision making, and ultimately to improved access to safe and effective drugs. This management report will:
-- Explain the scope and general principles of the ICH E8(R1) guideline
-- Describe the impact on current research practices that could influence
SOPs, procedures, processes and documentation
-- Describe the framework and approaches for identifying
critical-to-quality factors
-- Identify clinical development areas that may be impacted by the adoption
of the ICH E8(R1) guideline and approaches for compliance
Prepare for ICH E8(R1) now, June is only a few months away.
Management Report Details:
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
A CenterWatch Book
https://www.centerwatch.com/products/category/1105-books/product/435-the-revised-ich-e8-a-guide-to-new-clinical-trial-requirements-pdf
Management Report PDF:
$397
Easy Ways to Order:
Online: https://www.centerwatch.com/products/category/1105-books/product/435-the-revised-ich-e8-a-guide-to-new-clinical-trial-requirements-pdf
By phone: 888.838.5578 or 703.538.7600
About CenterWatch:
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.
SOURCE CenterWatch
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
|
